SCHEMBL7079376

SCHEMBL7079376

Cn1cccc1C(=O)c1ccc(Nc2ccccc2[N+](=O)[O-])cc1Cl

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 10/20 0.67
MAPK12 P53778 10/20 0.67
MAPK11 Q15759 10/20 0.67
MAPK14 Q16539 10/20 0.67
SMN1; SMN2 Q16637 1/20 0.54
HSD17B10 Q99714 1/20 0.54
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
TDP1 Q9NUW8 3/20 0.45
MAPT P10636 2/20 0.45
MAPK1 P28482 2/20 0.45
GAA P10253 1/20 0.45
PKM P14618 1/20 0.45
ALDH1A1 P00352 3/20 0.44
LMNA P02545 1/20 0.44
XBP1 P17861 1/20 0.44
HTT P42858 1/20 0.44
CASP7 P55210 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
EPAS1 Q99814 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7075678 0.89 MAPK13 (0.58) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL7075166 0.87 MAPK13 (0.56) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL7075172 0.87 MAPK13 (0.56) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL7076455 0.84 MAPK14 (0.68) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL7076539 0.83 MAPK13 (0.64) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL7080033 0.83 MAPK14 (0.65) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL6657882 0.81 MAPK13 (0.73) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL6655015 0.81 MAPK14 (1.00) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL6655495 0.80 MAPK14 (0.82) MAPK13MAPK12MAPK11MAPK14MEN1
SCHEMBL16634680 0.80 MAPK13 (0.71) MAPK13MAPK12MAPK11MAPK14MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
WO-2002083622-A2 NOVEL AMINOPHENYL KETONE DERIVATIVES LEO PHARMA A/S (DK) 2002-10-24 WO claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed
WO-2002083622-A2 NOVEL AMINOPHENYL KETONE DERIVATIVES LEO PHARMA A/S (DK) 2002-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 MAPK13 33/4885MAPK12 36/4885MAPK11 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.